StonvexLoading…
StonvexStonvexStonvexCore line items from CHD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.20B | $6.11B | $5.87B | $5.38B |
Operating Income | $1.08B | $807.10M | $1.06B | $597.80M |
Net Income | $736.80M | $585.30M | $755.60M | $413.90M |
EPS (Diluted) | $3.02 | $2.37 | $3.05 | $1.68 |
Total Assets | $8.91B | $8.88B | $8.57B | $8.35B |
Total Liabilities | $4.91B | $4.52B | $4.71B | $4.86B |
Cash & Equivalents | $409.00M | $964.10M | $344.50M | $270.30M |
Free Cash Flow OCF − CapEx | $1.09B | $976.40M | $807.10M | $706.40M |
Shares Outstanding | 244.30M | 246.90M | 247.60M | 246.30M |